Release Date: 18/03/14 10:16 Summary: MTE: Bidders Statement - Market bid Price Sensitive: Yes Download Document 1.36MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%